Warning: Declaration of AMW_Related_Sub_Items_Walker::walk($elements, $max_depth) should be compatible with Walker::walk($elements, $max_depth, ...$args) in /home/cnmhopkins/www/www/wp-content/plugins/advanced-menu-widget/class-advanced-menu-walker.php on line 163
Research : Center for Nanomedicine

Research

Nanomedicine for Inflammation

Filed in Research by on August 9, 2013
Nanomedicine for Inflammation

gastrointestinalThe cells and tissues of the immune system work together in an intricate and complex way to maintain health. Inflammation is a general term that …

Continue Reading »

Nanomedicine for Cancer

Filed in Research by on August 9, 2013
Nanomedicine for Cancer

cardiovascularCancers are as diverse as they are devastating. Drugs that kill tumor cells, known as chemotherapy, are administered systemically (through the blood). The major limitation

Continue Reading »

Patents

Filed in Research by on May 10, 2013
  1. Hanes J, Fiegel J, and Fu J, Biodegradable polymer compositions: Compositions and uses related thereto, U.S. Patent No. 7,163,697 B2.  Granted January 16, 2007.
  2. Edwards,

Continue Reading »

Nanomedicine for Eye Diseases

Filed in Research by on April 18, 2013
Nanomedicine for Eye Diseases

Nanomedicine Breakthrough for Eye Disease

As reported in 2012 in an article published in Biomaterials, Center for Nanomedicine members, Rangaramanujam Kannan, Jie Fu, Manoj Mishra and others have shown that a nanomedicine platform technology, called “dendrimers,” can be used to effectively deliver medicines to activated microglia--key players in many blinding ocular diseases, such as Age-related Macular Degeneration (AMD).

Learn more about dendrimers and our research for eye diseases.

Continue Reading »

Nanomedicine for Women’s Health

Filed in Research by on April 4, 2013
Nanomedicine for Women’s Health

Nanomedicine for Women’s Health

In an article published in Science Translational Medicine on June 13, 2012, Center for Nanomedicine members Laura Ensign, Richard Cone, Justin Hanes and others have shown that a nanomedicine platform technology developed at CNM, called “mucus penetrating particles,” can deliver microbicides effectively and protect against herpes virus (HSV-2) infection in the mouse female reproductive tract.

Learn more about our platform technologies and our research on women's health.

Continue Reading »

Nanomedicine for Central Nervous System Diseases

Filed in Research by on April 18, 2012
Nanomedicine for Central Nervous System Diseases

Nanomedicine Breakthrough for Cerebral Palsy

As reported April 18, 2012 in an article published in Science Translational Medicine, Center for Nanomedicine faculty, Rangaramanujam and Sujatha Kannan, a husband and wife team, have developed a new nanomedicine that reverses the effects of cerebral palsy in a rabbit model of the devastating disease.

Learn more about our research on the Central Nervous System.

Continue Reading »

Facilities

Filed in Research by on April 20, 2013

The Johns Hopkins research community is extremely diverse and rich. More than 50 State-of-the-Art Core Facilities are within walking distance on the JHU School of …

Continue Reading »

Research

Filed in Research by on April 20, 2013

The Center for Nanomedicine engineers drug and gene delivery technologies that have significant implications for the prevention, treatment, and cure of many major diseases facing …

Continue Reading »

Nanomedicine for Cardiovascular Diseases

Filed in Research by on April 20, 2013
Nanomedicine for Cardiovascular Diseases

cardiovascular

Coming soon, please check back.

Disease focus areas:

  • Cardiac Arrest, also known as cardiopulmonary arrest or circulatory arrest, is the cessation of normal circulation of

Continue Reading »

Nanomedicine for Gastrointestinal Tract (GI) Diseases

Filed in Research by on April 18, 2013
Nanomedicine for Gastrointestinal Tract (GI) Diseases

The GI is a favored site for drug delivery, both colorectally and orally. However, there are many barrier mechanisms in the GI to protect the …

Continue Reading »